title: Distortion of the terminal portion of the QRS on the admission electrocardiogram in acute myocardial infarction and correlation with infarct size and long-term prognosis (Thrombolysis in Myocardial Infarction 4 Trial).
abstract: Previous studies have shown an association between distortion of the terminal portion of the QRS (QRS[+] pattern: emergence of the J point > or = 50%. of the R wave in leads with qR configuration or disappearance of the S wave in leads with an Rs configuration) on admission and in-hospital mortality in acute myocardial infarction (AMI). However, the mechanism for this association is not known. We assessed the relation between QRS(+) pattern and coronary angiographic findings, infarct size, and long-term prognosis in the Thrombolysis In Myocardial Infarction 4 trial. Patients were allocated into 2 groups based on the presence (QRS[+], n = 85) or absence (QRS[-], n = 293) of QRS distortion. The QRS(+) patients were older (mean +/- SD: 61.1 +/- 10.6 vs 57.5 +/- 10.6 years, p = 0.004), had more anterior AMI (49% vs 37%, p = 0.04), and less previous angina (42% vs 54%, p = 0.05). QRS(+) patients had larger infarct size as assessed by creatine kinase release over 24 hours (209 +/- 147 vs 155 +/- 129, p = 0.003), and predischarge sestamibi (MIBI) defect (17.9 +/- 15.9% vs 11.2 +/- 13.4%, p <0.001). When adjusting for difference in baseline characteristics, p values for the differences in 24-hour creatine kinase release were 0.03 and 0.64 for anterior and nonanterior AMI, respectively, and for MIBI defect size 0.03 and 0.02, respectively. One-year mortality (18% vs 6%, p = 0.03) was higher and the weighted end point of death, reinfarction, heart failure, or left ventricular ejection fraction <40% (0.33 +/- 0.37 vs 0.24 +/- 0.32, p = 0. 13), tended to be higher in the anterior AMI patients with QRS(+). No difference in clinical outcome was found in patients with non-anterior AMI. These findings suggest that this simple electrocardiographic definition of presence of QRS(+) pattern on admission may provide an early estimation of infarct size and long-term prognosis, especially in anterior AMI.
authors: The Heart Institute, Good Samaritan Hospital, Los Angeles, California, USA.
authors: Y
authors: Y
authors: Birnbaum
authors: R A
authors: RA
authors: Kloner
authors: S
authors: S
authors: Sclarovsky
authors: C P
authors: CP
authors: Cannon
authors: C H
authors: CH
authors: McCabe
authors: V G
authors: VG
authors: Davis
authors: B L
authors: BL
authors: Zaret
authors: F J
authors: FJ
authors: Wackers
authors: E
authors: E
authors: Braunwald
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D000787:Angina Pectoris / Q000503:physiopathology; D002303:Cardiac Output, Low / Q000209:etiology / Q000503:physiopathology; D017023:Coronary Angiography; D003402:Creatine Kinase / Q000097:blood; D004311:Double-Blind Method; D004562:Electrocardiography / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology*; D010343:Patient Admission; D011379:Prognosis; D012008:Recurrence; D012189:Retrospective Studies; D013318:Stroke Volume; D015996:Survival Rate; D017256:Technetium Tc 99m Sestamibi; D015912:Thrombolytic Therapy; D016896:Treatment Outcome; D016277:Ventricular Function, Left
chemical_list: D017256:Technetium Tc 99m Sestamibi; D003402:Creatine Kinase